| Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924) |
|---|
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/22/2004 | US20040077625 Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/14/2004 | EP1407782A1 Preventives/remedies for organ functional disorders and organ dysfunction |
| 04/14/2004 | EP1406881A1 11-piperazinyldibenzo(b,f)(1,4)oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 04/14/2004 | CN1145619C 1-4-benzothiazepine derivatives methods for preparation, medicaments containing same and use thereof |
| 04/14/2004 | CN1145488C Sustained-release microgranules containing diltiazem as active principle |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/06/2004 | US6716835 Use of diltiazem for treating retinal pathologies |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058910 Drug abuse, alcoholism, tobacco |
| 03/25/2004 | US20040058909 Method of treatment |
| 03/17/2004 | EP1305318B1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3]benzothiazepines |
| 03/17/2004 | EP1252151B1 A process for the preparation of quetiapine and intermediates therefor |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/11/2004 | WO2004020421A1 Novel quaternary ammonium compounds |
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/19/2004 | US20040034010 Administering an effective amount of quetiapine or a salt to a patient having attention deficit hyperactivity disorder or conduct disorder |
| 02/12/2004 | US20040029845 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 01/29/2004 | WO2004009530A1 Process for production of high-purity enamines |
| 01/28/2004 | CN1136205C Method for preparing 1,5-benzo thia azatropy olerivative |
| 01/13/2004 | CA2242224C Sustained-release microgranules containing diltiazem as the active principle |
| 12/18/2003 | WO2003104257A2 Protease inhibitors |
| 12/17/2003 | CN1462269A Fused azepine drivatives and their use as antidiuretic agents |
| 12/17/2003 | CN1131202C Calcium receptor-active compounds |
| 12/09/2003 | US6660296 Neutral granular support coated with an active layer comprising: Diltiazem or a salt, a surfactant, and a binder, and a layer which ensures sustained release of the active principle |
| 12/04/2003 | WO2003018019A3 New use of cyclic compounds |
| 11/20/2003 | US20030216376 Crystalline forms of quetiapine hemifumarate |
| 11/12/2003 | EP1359919A1 Method of treating substance abuse with quetiapine |
| 11/05/2003 | EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 10/23/2003 | US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2 |
| 10/22/2003 | CN1125058C Crystalline dibentothiazepine derivatives and its use as antipsychotic agent |
| 10/09/2003 | US20030191049 Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 10/07/2003 | US6630462 Delta agonist analgesics |
| 10/02/2003 | WO2003080065A1 Crystalline forms of quetiapine hemifumarate |
| 10/02/2003 | US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents |
| 10/02/2003 | CA2479668A1 Crystalline forms of quetiapine hemifumarate |
| 10/01/2003 | EP1347967A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 10/01/2003 | CN1122670C Thiazolobenzoheterocycles, prepn method and medicines containing same |
| 09/30/2003 | US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 09/25/2003 | US20030181437 By reaction of pyrrolobenzothiazepin-9-one with amine to give the corresponding enamine, which is subsequently transformed into the final compound |
| 09/24/2003 | EP1345918A1 Chemical compounds |
| 09/24/2003 | EP1345610A1 Method of treatment |
| 09/18/2003 | US20030176485 Calcium receptor active compounds |
| 09/17/2003 | CN1443188A Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines |
| 09/17/2003 | CN1121395C Compounds potentiating retinoid |
| 09/17/2003 | CN1121383C Process for recycle of waste product of diltiazem synthesis |
| 09/16/2003 | CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures |
| 09/04/2003 | US20030166927 1,5-Benzothiazepines and their use as hypolipidaemics |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 08/14/2003 | US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/30/2003 | CN1116029C Tablet allowing prolonged release of sodium salt of tianeptine after administration by oral |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/17/2003 | US20030135042 Atypical antipsychotic agents having low affinity for the D2 Receptor |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/16/2003 | EP1326616A1 New use of quetiapine |
| 07/09/2003 | EP1324993A2 Substituted 1,4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/02/2003 | EP1322314A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 06/25/2003 | EP1235792A4 Preparation of [4s-(4alpha,7alpha,10abeta)]-4-amino-octahydro-5-oxo-7h-pyrido 2,1-b] 1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides |
| 06/25/2003 | EP1169313B1 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/18/2003 | CN1425010A Cyclic compound |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/13/2003 | US6562860 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 05/13/2003 | US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 05/07/2003 | CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics |
| 05/02/2003 | EP1305318A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo 2,1-b] 1,3]benzotiazepines |
| 05/02/2003 | EP0868184B1 Sustained-release microgranules containing diltiazem as the active principle |
| 04/30/2003 | CN1414958A Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 04/17/2003 | WO2003031376A1 Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/15/2003 | CA2024124C Heterogeneous synthesis of azepinones from esters |
| 04/09/2003 | EP0799220B1 Polymerisable monomers and polymers |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 03/27/2003 | WO2003024941A1 Naphthalene compounds and use thereof as drugs |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/20/2003 | WO2003022825A1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 03/20/2003 | WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 03/20/2003 | CA2459457A1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 03/13/2003 | WO2003020710A1 Benzothiazepine derivatives |
| 03/13/2003 | WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 03/13/2003 | CA2459346A1 Benzothiazepine derivatives |
| 03/06/2003 | WO2003018019A2 New use of cyclic compounds |
| 03/06/2003 | WO2003018009A1 A combination of quetiapine and zolmitriptan |
| 03/06/2003 | CA2456480A1 A combination of quetiapine and zolmitriptan |
| 02/27/2003 | WO2003016294A1 Process for preparing sultams |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/20/2003 | WO2001079187A8 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/18/2003 | US6521445 Stereoselective ester hydrolysis of racemic trans-3-(4-methoxyphenyl) glycidic acid ester using a hydrolase enzyme; resolution; diltiazem production |
| 02/12/2003 | CN1396916A Process for preparation of quetiapine and intermediates therefor |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 01/22/2003 | EP1276729A1 New neurokinin antagonists for use as medicaments |